Targeted therapies: Combined lapatinib and paclitaxel in HER2-positive breast cancer

Producción científica: Contribución a una revista › Artículo › revisión exhaustiva

Idioma original	Inglés
Páginas (desde-hasta)	308-309
Número de páginas	2
Publicación	Nature Reviews Clinical Oncology
Volumen	6
N.º	6
DOI	https://doi.org/10.1038/nrclinonc.2009.68
Estado	Publicada - 2009
Publicado de forma externa	Sí

Acceder al documento

@article{747afd52cb964497af9fd55b8402fc6a,

title = "Targeted therapies: Combined lapatinib and paclitaxel in HER2-positive breast cancer",

author = "Casta{\~n}eda, {Carlos A.} and Gomez, {Henry L.}",

year = "2009",

doi = "10.1038/nrclinonc.2009.68",

language = "Ingl{\'e}s",

volume = "6",

pages = "308--309",

journal = "Nature Reviews Clinical Oncology",

issn = "1759-4774",

publisher = "Nature Publishing Group",

number = "6",

}

TY - JOUR

T1 - Targeted therapies

T2 - Combined lapatinib and paclitaxel in HER2-positive breast cancer

AU - Castañeda, Carlos A.

AU - Gomez, Henry L.

PY - 2009

Y1 - 2009

UR - http://www.scopus.com/inward/record.url?scp=68549121149&partnerID=8YFLogxK

U2 - 10.1038/nrclinonc.2009.68

DO - 10.1038/nrclinonc.2009.68

M3 - Artículo

C2 - 19483734

AN - SCOPUS:68549121149

SN - 1759-4774

VL - 6

SP - 308

EP - 309

JO - Nature Reviews Clinical Oncology

JF - Nature Reviews Clinical Oncology

IS - 6

ER -